Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Principal Accounting Officer
-
Stock Symbol
-
ACAD on Nasdaq
James Kihara - trading volume in the past year for Acadia Pharmaceuticals Inc
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
14.4K |
$243K |
$16.94 |
May 2, 2024 |
Direct |
|
|
| Restricted Stock Units |
7.79K |
$132K |
$16.94 |
May 1, 2024 |
Direct |
Common Stock |
|
| Stock Options (Right to Buy) |
14K |
|
|
Mar 25, 2024 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.